GSK Pharma put volume heavy and directionally bearish
Bearish flow noted in GSK (GSK) Pharma with 5,611 puts trading, or 3x expected. Most active are Mar-25 36.5 puts and 3/14 weekly 39.5 calls, with total volume in those strikes near 6,100 contracts.
moneycontrol.com23d
GSK Pharma shares jump 15%, extend gains to 2nd straight day after strong Q3 results
The shares of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) jumped over 15 percent to trade at Rs 2,684 apiece on February 18, extending gains for the second straight session after releasing ...
Business Insider10d
GSK Pharma put volume heavy and directionally bearish
Bearish flow noted in GSK (GSK) Pharma with 4,314 puts trading, or 4x expected. Most active are Mar-25 38.5 puts and Apr-25 37 puts, with total volume in those strikes near 3,200 contracts.
Yahoo Finance19d
GSK plc (GSK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other ...
Fierce Pharma3d
GSK, Novartis, Lilly among Big Pharmas celebrating International Women’s Day 2025
Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...
BioSpace14d
GSK CEO Emma Walmsley Gets Pay Bump To Align With Pharma Peers
One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...
STAT1d
Warren asks HHS watchdog to investigate GSK over its asthma inhaler maneuvers
After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...
Pfizer is latest Big Pharma to overhaul DEI goals after GSK
Pfizer (NYSE:PFE) and GSK (NYSE:GSK) revamp DEI initiatives, emphasizing merit-based diversity amid changing U.S. policies.
The Financial Express27d
Q3FY25: GSK pharma’s profit surges 4X to Rs 229 crore; Revenue up 18 percent
GlaxoSmithKline Pharmaceuticals Ltd (GSK) on Friday announced its financial results for the third quarter ended December 31, 2024. According to the company’s exchange filing, it demonstrates ...
Mint24d
GlaxoSmithKline Pharmaceuticals shares hit 20% upper circuit as profit jumps fivefold in Q3FY25
Commenting on the results, Bhushan Akshikar, MD of GlaxoSmithKline Pharmaceuticals, highlighted the company’s strategic initiatives in strengthening its market presence and enhancing access to ...
Reuters28d
India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs
Feb 13 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and ...
moneycontrol.com25d
GSK Pharma shares gain 20% following strong Q3FY25 results
GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline ...